January 7, 2026
Mediar Therapeutics
Mediar is a pre-clinical stage biotechnology company...
- Round
- Series B
- Amount raised
- $76M
- Lead investor
- Amplitude Venture Capital
- Industry
- Biotechnology
- Headquarters
- Boston, Massachusetts
- Employees
- 11-50
- Website
- www.mediartx.com
- —